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The effect of the eye movement desensitization and reprocessing intervention 
on anxiety and depression among patients undergoing hemodialysis: A 
randomized controlled trial 
 
Abstract 
PURPOSE: This study investigated the effect of the eye movement desensitization and 
reprocessing intervention on depression and anxiety levels in patients undergoing hemodialysis.  
DESIGN AND METHODS: In this randomized controlled trial, ninety patients were enrolled. The 
intervention group received six sessions of eye movement desensitization and reprocessing 
therapy. Data was collected prior to and two weeks after the intervention using the Hospital 
Anxiety and Depression Scale. 
FINDINGS: Measured levels of anxiety and depression were significantly lowered in the 
intervention group compared to pre-intervention results and to the control group.  
PRACTICE IMPLICATIONS: 
Eye movement desensitization and reprocessing should be considered a complementary and 
alternative treatment for the reduction of depression and anxiety in patients undergoing 
hemodialysis.  
 
Keywords: anxiety, eye movement desensitization and reprocessing, depression, hemodialysis, 
nursing 
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INTRODUCTION 
Patients with end-stage renal disease (ESRD) have a renal function that cannot sustain life 
without kidney transplantation or replacement therapies such as hemodialysis. It has been 
reported that one million patients across the world are undergoing maintenance hemodialysis. 
Also, it has been estimated that by 2030 this number will exceed two million indicating a global 
health challenge (Bujang, Adnan & Hashim, 2017). Patients with ESRD on lifelong maintenance 
hemodialysis have complex healthcare needs related to the physical and psychological effects of 
ESRD, its treatment and comorbidities (Davaridolatabadi & Abdeyazdan, 2016).  
 
Psychological issues among hemodialysis patients 
Adherence to the hemodialysis regimen requires that the patient adapts to a number of life 
affecting restrictions such as fatigue and lack of energy, sexual dysfunction, fluid and diet 
control, fistula cannulation, and frequent hospital readmissions (Delmas et al., 2018; Smith, 
2016). Since the process of hemodialysis often limits patients’ ability to carry out activities of 
daily living (ADLs) plus financial challenges (Kutner, Zhang, Allman & Bowling, 2014), high 
levels of mental stress is often experienced by them (Gerogianni & Babatsikou, 2013). 
Psychological issues such as anxiety, depression and suicidal ideation are prevalent among 
patients with ESRD and increase in proportion to the degree of renal decline (Jhee et al., 2017). 
These psychological issues are associated with a poor quality of life (QoL) (Gerasimoula et al., 
2015), increased rate of hospital readmissions and longer lengths of hospital stay (Najafi, 
Keihani, Bagheri, Jolfaei & Meybodi, 2016). The consequences of hemodialysis such as fatigue 
and loss of appetite can make it difficult to differentiate anxiety and depression from the physical 
effects of treatment (Picariello, Moss-Morris, Macdougall, & Chilcot, 2017). While anxiety and 
depression are common in hemodialysis patients, they are often not diagnosed. Therefore, failure 
to diagnosis anxiety and depression may result in treatment non-compliance or physical 
presentations including palpitations and indigestion (Cohen, Cukor & Kimmer, 2016).   
Ng, Tan, Mooppill, Newman and Griva (2015) described a 44.7-54.1% prevalence of depression 
and anxiety in hemodialysis patients following a 12-month study (n=159). Depression is 
associated with sorrow, helplessness, despair, guilt, sleep disturbances, decreased appetite and 
sexual desire disorders (Cohen et al., 2016). Depression can reduce health-related QoL and 
adversely affect morbidity and mortality in hemodialysis patients (Preljevic et al. 2013). Najafi, 
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et al., (2016) reported a high prevalence of untreated depression in patients on maintenance 
hemodialysis, with over 70% of patients demonstrating indices of depression and anxiety. 
However, it was noted that patients were unaware of their symptoms and did not acknowledge 
any need for treatment. Liu et al. (2018) in a study of 194 older patients receiving maintenance 
hemodialysis reported that 45.9% of these patients experienced depressive symptoms and 
contended that the severity of symptoms and degree of inability to undertake ADLs were the 
major causes of depressive symptoms. Additionally, there are biologic mechanisms that cause 
poorer medical outcomes in patients with depression; for instance, depression can lead to an 
increase in inflammation, that accelerate atherosclerosis and an increased risk of cardiovascular 
diseases (Shirazian et al., 2017). If hemodialysis guidelines do not screen patients routinely for 
mental health issues, the potential to detect depression and anxiety is reduced. Untreated mental 
health illness contributes to increased morbidity and mortality, reduced QoL and increased risk 
of suicidal ideation of this patient group (Fan et al., 2014).  
 
Methods to treat anxiety and depression in hemodialysis patients  
Pharmacological and non-pharmacological treatments can be used to reduce anxiety and 
depression in hemodialysis patients (Grigoriou et al., 2015). Drugs used for relieving anxiety and 
depression have many side effects such as increased levels of toxic metabolites in the blood, 
cardiovascular disorders, anorexia and vomiting, hepatotoxicity and risk of bleeding (Rezaei et 
al., 2015). Patients on hemodialysis are at a particular risk of altered pharmacokinetics. For 
instance, due to renal impairment, drug clearance is impaired and suitable dosage adjustment, 
care with prescription timing and careful monitoring of medication are essential (Cohen et al., 
2016). Whilst current guidelines recommend the use of a selective serotonin reuptake inhibitor to 
treat depression in this patient group, there is a paucity of evidence related to the use of 
antidepressant medications. Additionally, there is no conclusive data on the relative risks and 
benefits of such drug use (Palmer et al., 2016). Therefore, non-pharmacological methods are 
preferable to pharmacological methods for relieving depression and anxiety in hemodialysis 
patients due to the low risk of side effects, low costs and limited potential for drug dependency 
(Grigoriou, Karatzaferi & Sakkas, 2015). Concerns about drug-induced side effects in 
hemodialysis patients have increased interests in the use of psychological therapies and 
complementary and alternative medicine approaches. It has been shown that non-
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pharmacological methods such as meditation, hypnotism, progressive muscle relaxation and 
cognitive behavior therapy (CBT) (Duarte et al. 2016), and regular exercise (Rezaei et al. 2015) 
can reduce anxiety and depression in hemodialysis patients. The use of relaxation interventions 
such as Benson’s relaxation has been shown to prevent further health-related complications in 
hemodialysis patients through reducing anxiety and stress (Otaghi, Borji., Bastami, & 
Solymanian, 2016). Hemodialysis patients who have received acupuncture on a regular basis 
demonstrate significant reductions in depression, anxiety and general psychological distress 
compared to the control group (Hmwe, Subramanian, Tan & Chong, 2015). Grigoriou et al., 
(2015) argue that the treatment of depression in hemodialysis patients should be a 
multidimensional approach with the use of different strategies drawing on the skills of the whole 
healthcare team. Nurses are responsible for the provision of mental health care alongside 
physical care and their role includes patients’ education to improve their mental health and 
prevent psychological problems (Happell, Platania-Phung & Scott, 2013). One of the non-
pharmacological therapeutic interventions that can be used by nurses is the Eye Movement 
Desensitization and Reprocessing (EMDR) therapy.  
 
Eye Movement Desensitization and Reprocessing (EMDR) therapy 
EMDR is an inexpensive, safe and non-invasive treatment atth   has been endorsed by the 
American Psychiatric Association (Shapiro & Threlfo 2002). In 2013, the World Health 
Organization (WHO) recognized EMDR as a psychotherapy intervention for the treatment of 
post-traumatic stress disorder (PTSD) (Valiente-Gomezet al., 2017). 
The underpinning assumption of EMDR therapy is that anxiety as the product of distressing 
events have not been properly processed by the nervous system, leading to isolated 
neurobiological stasis (Shapiro 2002). This therapy has been developed initially for the treatment 
of PTSD and is guided by the use of a behavioral-cognitive technique on the basis of the 
adaptive information processing model (Amano & Toichi 2016; Mazzola et al., 2016). 
Distressing unprocessed events can lead to prolonged negative consequences such as anxiety and 
depression. Therefore, the aim of EMDR is to process and resolve any such underlying 
unprocessed events, that may cause negative mental consequences (Oren & Solomon, 2012).  
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The guided eye movements used in EMDR immediately activate the parasympathetic nervous 
system and lead to physiological responses (Lee & Cuijpers, 2013). During EMDR, alternating 
left-right simulation of the brain by eye movements, sounds or taps is sought, although the mind 
is focused on troublesome issues in life for stimulating the blocked or frozen information 
processing system (Benor et al. 2016;  Marofi, Maroufi, Zamani-Foroshani, Allimohammadi, & 
Izadikhah,  2016). The patient is asked to focus on the causes of negative life issues and their 
consequences, whilst simultaneously is attending to the alternate stimulus producing eye 
movements or other forms of bilateral stimulations (Oren & Solomon 2012). While the patient 
focuses on a memory or negative experience, he/she is asked to report new thoughts that have 
emerged in an iterative process until the memory or experience is no longer experienced as 
distressing (Shapiro, 2014).  
Schneider et al. (2005) state that EMDR is a significant treatment for reducing depression and 
anxiety. Behnammoghadam,  Alamdari, Behnammoghadam, &  Darban (2015) and Hase et al., 
(2015) reported statistically significant reductions in the depressive symptom of patients after the 
use of EMDR. Staring et al. (2016) compared the effects of EMDR and Competitive Memory 
Training (COMET) used in combination in patients with anxiety (n=47). They indicated that the 
use of EMDR therapy mediated reductions in anxiety and depression symptoms. However, 
COMET was associated with more improvements in self-esteem. The use of EMDR therapy has 
demonstrated positive effects on patients with PTSD (Sadeghi et al. 2015), QoL in patients with 
myocardial infarction (Salehian et al., 2016) and pre-operative anxiety in children (Marofi, 
Marofi, Zamani-Foroshani & Izasikhah, 2016). Chen, Zhang and Liang (2015) following a 
systematic review compared EMDR and CBT in adult patients with PTSD and suggested that 
EMDR could be more suitable for this patient group.  Valiente-Gomez et al. (2017), following a 
systematic review of randomized controlled trials (RCTs) that used EMDR therapy noted that 
there were few such studies. They argued that despite the presence of limited evidence, EMDR 
could be effective in mental disorder related to trauma, psychotic or affective symptoms and 
chronic pain. Gauhar (2016) reported that after only 6-8 sessions of EMDR in patients with 
depression, negative thoughts and depressive moods were decreased significantly compared to 
the control group and reported a maintained improvement in mood at a three-month follow up 
interview.  
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No English language literature was discovered on the use of EMDR in hemodialysis patients 
with anxiety or depression. Rahimi, Rejeh, Karimooi and Tadrisis (2016) reported in Farsi a 
randomized clinical trial utilizing the Hemodialysis Stress Scale questionnaire (HSS-Baldree) on 
the effect of EMDR on psychological stress in patients undergoing hemodialysis. They reported 
that EMDR was beneficial in decreasing patients’ stress. The aim of this study was to investigate 
the effect of EMDR on depression and anxiety levels among hemodialysis patients. 
 
METHODS 
Design 
This was a randomized controlled trial. Subjects were recruited from high-turnover hemodialysis 
units in two large tertiary referral teaching hospitals in an urban area of Iran. Data was collected 
from December 2015 to July 2016. 
Sampling 
A total of 90 patients were randomly assigned into intervention (n=45) and control (n=45) 
groups. The sample size estimation was based on the primary outcome data from a previous 
study (Arefi et al. 2012), power 80%, α = 0.05, and β = 20%. The following sampling formula 
for two-tailed comparison groups was used (Machin, Campbell, Tan & Tan, 2009):  
 
 (1.96+0.85) 2  (4.072+3.022) /(9.95-7.86)2 =90  
Therefore, 45 patients were required for each intervention and control group. The subjects were 
considered eligible, if they met the following inclusion criteria: willingness to participate in this 
study, were on hemodialysis at least for six months (it was adjudged that this amount of time 
would allow for transition and adjustment to the process of hemodialysis), was receiving 
treatment three times a week, were over 18 years of age, had no history of seizure and 
hospitalization due to psychiatric disorders, lack of addiction to drugs or alcohol, lack of 
strabismus and visual problems based on the researcher’s physical examination, no 
consciousness issues, ability to communicate in Farsi, no stressful life events in the last six 
months such as the death of a family member, and no previous use of EMDR. Also, those 
patients who were unwilling to continue with the study or experienced any critical physical and 
psychological conditions would be excluded from the study.  
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Procedure 
Nurse managers in the hemodialysis wards were informed of the study’s aim, procedure and 
inclusion criteria to help with the identification of eligible subjects. A convenience sample of 
patients undergoing hemodialysis who met the inclusion criteria was identified, with no patient 
declining to participate. After explaining the aim and method of the study to eligible patients, an 
informed written consent form was signed by them. There was no remuneration for the subjects. 
Subjects were allocated to the groups randomly through a system of sealed envelopes, with each 
envelope noting assignment to a specific group. The sampling process was continued until the 
required number of subjects was assigned to each group. To avoid selection bias, the primary 
researcher generated the random allocation sequence and the second researcher enrolled the 
patients, assigned them to the groups and approached them about participating in the study. A 
staff nurse in the hemodialysis ward, who was unaware of the subjects’ allocation, collected the 
data. Another person who was not a member of the research team fed data into the computer so 
that the researchers had no access to the data processing.   
The intervention group received EMDR therapy during hemodialysis six times (three times a 
week over two weeks) within a total four-week period (Shapiro, 2014). It was carried out for 30-
45 minutes in each session by the primary investigator (an experienced EMDR therapist). In the 
first session, the traumatic scenes of hemodialysis were identified. Next, the most disturbing 
scene for the patient was selected for desensitization. The aim of this phase was to familiarize the 
patient with EMDR and its positive and useful effects as a complementary and non-
pharmacological therapy in relieving anxiety and depression. This information also helped with 
patient participation and cooperation with the researcher when performing EMDR. The 
procedure was conducted according to the Shapiro protocol (Shapiro, 2014) as follows: 
• Facing the negative cognitions related to uncomfortable trauma: the patients were 
requested to describe their own understandings and visualizations of the traumatic event 
and recall it; 
• Mental rehearsal of the positive recognition; 
• Active visual attention to the object (finger movement): the finger rapidly was moved with 
approximately 30 centimeters distance from patient’s eyes in the visual field from right to 
left and vice versa. This included the sweep motion of the hand in the visual field, whilst 
the patient was visualizing the event successively; 
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• Stopping the thought or imagination; 
• Deep breathing after each session. 
The patients in the control group received routine care. The process of the study is shown in 
figure 1.  
Figure 1. The process of the study according to the Consort flow diagram (2010) 
Instruments 
Data was collected via a) a demographic and medical information form and b) use of the 
Hospital Anxiety and Depression Scale (HADS). 
The demographic and medical information form 
The demographic questionnaire included items related to the patients’ age, gender, education 
level, marital status, employment status, living status, history of hospitalization, underlying 
diseases, and history of hemodialysis. 
Hospital Depression and Anxiety Scale (HADS) 
The patients’ levels of anxiety and depression were assessed using the Farsi version of the 
Hospital Anxiety and Depression Scale (HADS). The HADS as a reliable and validated tool 
screened anxiety and depression (Marrie et al., 2018). This self-reporting tool is time efficient 
and despite its brevity, it has been shown to compare well with other measures such as the 
Beck’s Depression Inventory-II and other valid tools (Smarr & Keefer, 2011). The Farsi version 
of the HADS has an appropriate internal consistency for anxiety (r=0.78) and depression 
(r=0.86) based on the calculation of the Cronbach’s alpha coefficient (Montazeri et al. 2003). 
The HADS has been used in a previous study to measure the severity of anxiety and depression 
among hemodialysis patients. Also, it is easy to use and has general acceptability (Zhang, et al. 
2014). The basis of working with the above scale requires the patient’s own evaluation and self-
report of mental anxiety and depression. The tool is consisted of 14 items including two 
subscales of anxiety (HADS-A) and depression (HADS-D). Each subscale contains 7 items 
(anxiety items: 1, 3, 5, 7, 9, 11 and 13; depression items: 2, 4, 6, 8, 10, 12 and 14). The anxiety 
and depression subscales have a 4-point Likert scale from 0 (absence of symptoms) to 3 (the 
maximal presentation of symptoms), with a total score of 21. The scores are categorized as 
normal (0-7), borderline (8-10) and abnormal (11-21) (Zigmond & Snaith, 1983). Therefore, a 
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higher score indicates a higher level of anxiety or depression. Scores 11 or above on the anxiety 
or depression subscales indicate the probability of either anxiety or depression disorders.  
Data collection 
Baseline data was collected before the EMDR intervention and at the end of the second week. 
They were monitored closely for the occurrence of possible adverse effects during the 
intervention. 
Ethical considerations 
An ethical approval was obtained from the review board affiliated with Shahed University 
(decree code: 41-228111) before the study. In addition, the research protocol was registered in 
the Iranian Registry of Clinical Trials (code: IRCT201512 027529N8). Permissions were also 
obtained from the administrators of the hemodialysis wards. Potential subjects were given 
explanations about the purpose of the study and the EMDR intervention. They were informed 
that they could withdraw from the study at any time before the completion of the intervention 
without any effect on their care. Those patients who agreed to take part in this study were asked 
to sign the written informed consent form. The anonymity of the patients were ensured using 
code numbers instead of names.  
Data analysis 
Using the SPSS software v.21 (SPSS Inc., Chicago, IL) descriptive and inferential statistics were 
extracted to assess the impact of the intervention on anxiety and depression levels. The data was 
explored and assessed for missing values, outliers, extreme values and normal distributions. 
Descriptive statistics with the mean and standard deviation (SD) for continuous variables and 
frequency for categorical variables were used for the analysis of baseline data. 
Two tailed independent samples t-test, Chi-square and Fisher’s exact tests were used to assess 
whether there were any significant differences between patients’ characteristics, anxiety, and 
depression as recorded using the HADS. The level of statistical significance was considered 
P<0.05.  
 
RESULTS 
All 90 subjects fully participated throughout the study process.  
The demographic characteristics of the patients  
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The mean age of the subjects was 51.52±11.134 years, with an age range of 19-70 years. The 
majority of patients (52.2%) were male and the most prevalent comorbidities were hypertension 
(66.7%) and diabetes (56.7%). No statistically significant differences were reported in the 
baseline data between the groups (p>0.05). The baseline characteristics of the patients were 
reported in Table 1. 
The HADS 
No statistically significant differences were identified in depression and anxiety levels between 
the groups at the baseline (p>0.05). The level of anxiety was significantly lower in the 
intervention group after the EMDR intervention (p<0.05). Similarly, the patients’ level of 
depression was significantly lower in the intervention group after receiving the intervention 
(p<0.05) (Tables 2, 3). 
 
DISCUSSION 
This study investigated the effect of the EMDR intervention on anxiety and depression levels 
among patients undergoing hemodialysis. Results from this study supported the effectiveness of 
the EMDR therapy in decreasing anxiety and depression. The reduction of anxiety and 
depression levels in this study was consistent with the reported positive effect of EMDR therapy 
in the treatment of patients with various healthcare conditions and suffering from depression and 
anxiety as reported by Behnam Moghaddam et al. (2015), Gauhar, (2016), and Marofi et al. 
(2016).  
 Anxiety measure in the intervention group was reported as 12.27 ± 3.96 prior to the 
intervention. After the intervention, it showed an improvement and was reported as 7.27 ± 2.84. 
This compares unfavorably with the control group’s measure of 10.69 after the intervention 
period. Cohen et al., (2016) have argued that identifying and treating anxiety in hemodialysis 
patients can reduce irrational behaviors, conflicts with healthcare staff, and a behavioral 
noncompliance. While this study did not record any such patient behavior during this study, it is 
an area that is worthy of increased recognition by other researchers in future studies. Patients 
deserve the consideration of anxiety when noncompliance becomes a clinical concern. Anxiety 
relief, the improvement of patients QoL and treatment satisfaction also help with the reduction of 
the potential for the physiological effects of anxiety on the body (Shirazian et al., 2017). A 
reduction of the indices of depression (10.87 ± 3.32 reduced to 6.27 ± 2.10) in the intervention 
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group showed a marked difference from the control group (11.33 ± 3.14 after the intervention 
period) indicating the effectiveness of the intervention. Jhee et al., (2017) noted that the 
incidence of suicidal ideation as a consequence of depression was reported in 22% of patients 
undergoing hemodialysis. The psychological stress of ESRD and hemodialysis contribute to 
depression in this patient group as compared to the general population (Grigoriou et al., 2015) 
and our results supported this contention.  
The EMDR therapy was offered only six times, that was in line with accepted practice. Despite 
such relatively short intervention time frames compared to other standard psychological 
interventions such as CBT, a positive outcome was reported. Similarly, Shapiro (2014) reported 
that the EMDR therapy caused a rapid reduction of negative emotions and disruptive experiences 
among patients after a limited number of sessions. Therefore, EMDR decreases symptoms 
significantly faster than standard behavioral and cognitive techniques and fewer sessions are 
required to show its effect. The use of EMDR can help prevent the requirement to use 
pharmacological interventions in this groups of patients with a compromised renal function. 
Given the therapeutic effects of EMDR in reducing depression, it is recommended that this 
method is used to relieve anxiety and depression in patients suffering from other types of chronic 
diseases.  
The identification of depression and anxiety in patients was made easier by the use of the HADS 
questionnaire. According to Cohen et al., (2016), depression and anxiety are often undiagnosed 
in hemodialysis patients and symptoms can be mistaken for those of the renal impairment and/or 
the effects of hemodialysis (Picariello et al., 2017). The HADS can be used as a screening tool in 
this patient group given its ease of use and accessibility, and can be administered by clinical 
nurses as part of their routine patient assessment in hemodialysis wards. 
This was a small scale study and due to the nature of EMDR, the patients could not become blind 
to the intervention. A larger study is needed to compare and contrast other data collection 
instruments used to measure anxiety and depression. Nevertheless, validity and reliability of the 
HADS was supported in this study. Despite the small sample size and lack of stratification of 
patients, it was the first randomized controlled trial that used the EMDR intervention to relieve 
anxiety and depression among patients undergoing hemodialysis.  
 
IMPLICATIONS FOR NURSING PRACTICE  
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EMDR as a simple and easy to implement therapy can be educated to clinical nurses to be used 
for the promotion of patients’ psychological wellbeing. It can help with the reduction of the 
potential for side effects from pharmacological methods used for reliving patients’ anxiety and 
depression. It can help alleviate the negative physical and psychological effects of anxiety and 
depression on ESRD patients on maintenance hemodialysis, improve their QoL, reduce hospital 
readmissions, decrease healthcare costs and accelerate patients’ discharge from hospital. The 
authors hope that this research initiates a further use of EMDR therapy by nurses to help patients 
suffering from the common and debilitating disorder of renal failure. Anxiety and depression are 
often unrecognized in hemodialysis patients as symptoms can mimic the effects of ESRD 
coupled with the effects of hemodialysis. Nurses can use the HADS tool and help with the 
recognition of anxiety and depression in hemodialysis patients. Future studies should be 
conducted with a larger sample size and with longer follow up periods to assess the long-term 
effects of the EMDR intervention on patients’ anxiety and depression. In addition, a comparison 
of other non-pharmacological interventions with EMDR is suggested.   
REFERENCES 
 
Aghajani, M., Afaze, M.R. & Morasai, F. (2013). The effect of spirituality counseling on anxiety 
and    depression in hemodialysis patients. Evidence Based Care, 3, 19-28. 
Doi: 10.22038/EBCJ.2013.2016. 
Amano, T., & Toichi, M. (2016). The Role of Alternating Bilateral Stimulation in Establishing 
Positive Cognition in EMDR Therapy: A Multi-Channel Near-Infrared Spectroscopy Study. 
PLoS ONE, 11(10), e0162735.  
Arefi, S., Zakerimoghadam, M., Ghiasvandian, S., Haghani, H. (2012).  The effect of first phase 
cardiac rehabilitation programs on anxiety and depression in acute coronary syndrome patients. 
Cardiovascular Nursing Journal, 1,32-38. 
Barman, A., Chatterjee, A., & Bhide, R. (2016). Cognitive impairment and rehabilitation 
strategies after traumatic brain injury. Indian Journal of Psychological Medicine, 38, 172–181.  
Behnammoghadam, M., Alamdari, A.K., Behnammoghadam, A. & Darban, F. (2015). Effect of 
Eye Movement Desensitization and Reprocessing (EMDR) on Depression in Patients with 
Myocardial Infarction (MI). Global Journal Health Science, 7, 258-262. Doi: 
10.5539/gjhs.v7n6p258 
13 
 
Benor, D., Rossiter-Thornton, J. & Toussaint L. (2016). A Randomized, Controlled Trial of 
Wholistic Hybrid Derived From Eye Movement Desensitization and Reprocessing and 
Emotional Freedom Technique (WHEE) for Self-Treatment of Pain, Depression, and Anxiety in 
Chronic Pain Patients. Journal of Evidence Based Complementary and Alternative Medicine. 
[Epub ahead of print]  
Bujang, M.A., Adnan, T.H., Hashim, N.H. et al (2017) Forecasting the incidence and prevalence 
of patients with end-stage renal failure in Malaysia up to the year 2040. International Journal of 
Nephrology. 2017: 2735296  doi:10.1155/2017/273529 (Open Access) 1-5 
Chen, L., Zhang, G., Hu, M. & Liang, X. (2015) Eye movement desensitization and reprocessing 
versus cognitive-behavioral therapy for adult posttraumatic stress disorder: systematic review 
and meta-analysis. Journal of Nervous Diseases. 203, 443-451 
Cohen,S.D., Cukor, D., & Kimmer, P.L. (2016) Anxiety in patients treated with hemodialysis. 
Clinical Journal of the American Society of Nephrology, 12(12), 2250-2255. Doi: 
10.2215/CJN.02590316. 
Davaridolatabadi, E. & Abdeyazdan, G. (2016).The relation between perceived social support 
and anxiety in patients under hemodialysis. Electron physician, 8, 2144-2144. doi: 
http://dx.doi.org/10.19082/2144. 
Delmas, P., Cohen, C., Loiselle M-C, Antonini, M., Pasquier, J. &  Burnier, M. (2018) 
Symptoms and quality of life from patients undergoing hemodialysis in Switzerland. Clinical 
Nursing Studies. 6(2). 63-72. Doi: 10.5430/cns.v6n2p63 
Duarte, P.S., Miyazaki, M.C., Blay, S.L. & Sesso, R.(2009).Cognitive behavioral group therapy 
is an effective treatment for major depression in hemodialysis patients. Kidney International, 76, 
414-421. DOI: 10.1038/ki.2009.156 
Fan, L., Sarnak, M. J., Tighiouart, H., Drew, D. A., Kantor, A., Lou, K. V., … Weiner, D. E. 
(2014). Depression and All-Cause Mortality in Hemodialysis Patients. American Journal of 
Nephrology, 40, 12–18. http://doi.org/10.1159/000363539 
Gauhar,Y.W.M. (2016). The Efficacy of EMDR in the Treatment of Depression. Journal of 
EMDR Practice and Research, 10, 59-69. http://dx.doi.org/10.1891/1933-3196.10.2.59. 
14 
 
Gerasimoula K, Lefkothea L, Maria L, Victoria A, Paraskevi T, Maria P. (2015) Quality of life 
in hemodialysis patients. Materia Socio-Medica. 27, 305-309. doi:10.5455/msm.2015.27.305-
309. 
Gerogianni, G.K. & Babatsikou, F.P. (2013). Identification of stress in chronic hemodialysis. 
Health Science Journal.7, 169–176.  
Grant, M. & Threlfo, G. (2002).EMDR in the treatment of chronic pain. Journal of Clinical 
Psychology. 58, 1505–1520. 
Grigoriou, S.S., Karatzaferi, C. & Sakkas, G.K. (2015). Pharmacological and non-
pharmacological treatment options for depression and depressive symptoms in hemodialysis 
patients. Health Psychology Research. 3, 1811. Doi: 10.408/hpr.2015.1811. 
Happell, B., Platania-Phung, C & Scott, D. (2013). Are nurses in mental health services 
providing physical health care for people  with serious mental illness? An Australian perspective.   
Issues in Mental Health Nursing. 43, 198-207 Doi: 10.3109/01612840.2012.733907 
Hase, M., Balmaceda, U.M. & Hase, A. Lehnung, M., Tumani, V., Huchzermeier, C. & 
Hoffman, A. (2015). Eye movement desensitization and reprocessing (EMDR) therapy in the 
treatment of depression: a matched pairs study in an inpatient setting. Brain and Behavior.5(6), 
e00342.  
Hmwe, N.T.T., Subramanian, P., Tan, L.P., & Chong, W.K. (2015) The effects of acupuncture 
on depression, anxiety and stress in patients with hemodialysis: a randomized controlled trial. 
International Journal of Nursing Studies.  52. 509-518. Doi: 
http://dx.doi.org/10.1016/j.inursetu.2014.11.002 
Hosseini, SH., Espahbodi, F. & Mirzadeh Goudarzi SM. (2012).Citalopram versus psychological 
training for depression and anxiety symptoms in hemodialysis patients. Iranian Journal of 
Kidney Disease, 6, 446-451.  
Jhee, J.H., Lee, E., Cha, M.U. Kim, L.M.,  Park, S., … Park, J.T. (2017) Prevalence of 
depression and suicidal ideation increases proportionally with renal function decline, beginning 
from early stages of chronic kidney disease. Medicine 96 (44): e8476,  November 2017. DOI: 
10.1097/MD.0000000000008476 
Kimmel, P.L., Cukor, D., Cohen, S.D. & Peterson, R.A. (2007). Depression in end stage renal 
disease patients: A critical review. Advance Chronic Kidney Disease, 14, 328-334.  
15 
 
Kutner, N. G., Zhang, R., Allman, R. M., & Bowling, C. B. (2014). Correlates of ADL difficulty 
in a large hemodialysis cohort. Hemodialysis International. International Symposium on Home 
Hemodialysis, 18,1, 70-77. 10.1111/hdi.12098. http://doi.org/10.1111/hdi.12098 
Lee, C.W. & Cuijpers, P. (2013). A meta-analysis of the contribution of eye movements in 
processing emotional memories. Journal of Behavior Therapy and Experimental Psychiatry, 44, 
231-239. Doi: 10.1097/MD.0000000008476 
Liu, Y-M., Chang, H-J., Wang, R-H. Yang, L-K., Lu, K-C. & Hou, Y-C. (2018) Role of 
resilience and social support in alleviating depression in patients receiving maintenance 
hemodialysis, Therapeutics and Clinical Risk Management, 14, 441-451.  
Http://doi.org/10.2147/TCRM.S152273  
Marrie, R.A., Zhang, L., Lix, L.M., Graff, L.A. Walker, J.R., Fisk, J.D. …Bernstein, C.N. (2018) 
The validity and reliability of screening measures for depression and anxiety disorders in 
multiple sclerosis. Multiple Sclerosis and Related Dosorders. 20. 9-15. Doi: 
10.1016/j.msard.2017.12.007 
Marofi, M., Maroufi, M., Zamani-Foroshani, Sh., Allimohammadi, N. & Izadikhah, Z. (2016). 
Effect of Eye Movement Desensitization and Reprocessing (EMDR) Intervention on pre-
operative anxiety in patients undergoing surgery, International Journal of Nursing Research. 10, 
98-104.  
Mazzola, A., Leston, J. & Salvat, F. (2009).EMDR in the treatment of chronic pain. Journal of 
EMDR Practice and Research, 3, 66–79.  
Montazeri, M. Vahdaninia, M. Ebrahimi, M & Jarvandi, S. (2003).The Hospital Anxiety and 
Depression Scale (HADS): translation and validation study of the Iranian version, Health Quality 
Life Outcomes. 1, 1- 5. 
Najafi, A., Keihani, S., Bagheri, N., Ghanbari Jolfaei, A., & Mazaheri Meybodi, A. (2016). 
Association between anxiety and depression with dialysis adequacy in patients on maintenance 
hemodialysis. Iranian Journal of Psychiatry and Behavioral Sciences, 10(2), e4962. 
http://doi.org/10.17795/ijpbs-4962 
16 
 
Ng, H.J., Tan,W.J., Mooppil, N., Newman, S., & Griva , K. (2014) Prevalence and patterns of 
depression and anxiety in hemodialysis patients : a 12-month prospective study on incident and 
prevalent populations. The British Psychological Society. 20, 374-395 DOI: 10.1111/bjhp.12106 
Oren, E. & Solomon, R. (2012). EMDR therapy: an overview of its development and 
mechanisms of action. European Review of Applied Psychology, 62, 197–203. 
https://doi.org/10.1016/j.erap.2012.08.005 
Otaghi, M., Borji, M., Bastami, S., & Solymanian, L. (2016). The Effect of Benson's Relaxation 
on depression, anxiety and stress in patients undergoing hemodialysis. International Journal of 
Medical Research & Health Sciences, 5, 76-83 
Palmer, S.C., Natale, P., Ruospo, M., Saglimbene, V.M., Rabindranath, K.S., Craig, J.C., 
Strippoli, G.F.M. (2016). Antidepressants for treating depression in adults with end-stage kidney 
disease treated with dialysis. Cochrane Database of Systematic Reviews 2016, Issue 5. Art. No.: 
CD004541. DOI: 10.1002/14651858.CD004541.pub3. 
Picariello, F,  Moss-Morris, R. . Macdougall I.C., & Chilcot, J. (2017)  The role of psychological 
factors in fatigue among end-stage kidney disease patients: a critical review. Clinical Kidney 
Journal. 10,  1, 79–88. https://doi.org/10.1093/ckj/sfw113 
Preljevic, V.T., Østhus, T.B.H., Os I, et al. (2013).Anxiety and depressive disorders in dialysis 
patients: association to health-related quality of life and mortality. General Hospital Psychiatry, 
35,619-624. Doi: 10.1016/j.genhosppsych.2013.05.006 
Rahimi, F., Rejeh, N., Karimooi, M.H. & Tadrisi, D. (2016) Effect of eye movement 
desensitization and reprocessing on stress in patients undergoing hemodialysis. 11(5).1-6  Doi: 
10.21859/ijnr-11051 
Rezaei, J., Abdi, A., Rezaei, M., Heydarnezhadian, J.& Jalali, R. (2015). Effect of regular 
exercise program on depression in hemodialysis patients. International Scholary Research 
Notices, 6, 182030. 1-6.  http://dx.doi.org/10.1155/2015/182030 
Sadeghi, K., Arjmandnia, A. & Namjoo, S. (2015). Efficacy of Eye Movement Desensitization 
Reprocessing (EMDR) on negative emotional representations in people with post- traumatic 
stress disorder. Iranian Journal of Psychiatic Nursing, 3, 29-40.  
Salehian, T., Saeedinejad, S., Behnammoghadam, M., Shafiee, M., Mohammadhossini, S., 
Behnammoghadam,, Z…. Paymard, A. (2016) Efficacy of eye movements, densitization and 
17 
 
reprocessing on the quality of life of the patients with myocardial infarction. Global Journal of 
Health Science.  8, 112-117. Doi: 10.5539/gjhs.v8n10p112. 
Schneider, G., Nabavi, D. & Heuft, G. (2005). Eye movement desensitization and reprocessing 
in the treatment of posttraumatic stress disorder in a patient with co morbid epilepsy. Epilepsy 
and Behavior, 7, 715-718.  
Shapiro, F. (2001). Eye Movement Desensitization and Reprocessing: Basic Principles, Protocols 
and Procedures. Guilford Press, New York, NY.  
Shapiro, F. (2014). The role of eye movement desensitization and reprocessing (EMDR) therapy 
in medicine: addressing the psychological and physical symptoms stemming from adverse life 
experiences. Permanente journal, 18, 71-77.  
Shapiro, F. & Maxfield, L. (2002). Eye movement desensitization and reprocessing (EMDR): 
information processing in the treatment of trauma. Journal of Clinical Psychology, 58, 933–946. 
Smarr, K.L. & Keefer, A.L. (2011) Measures of depression and depressive symptoms. Arthritis 
Care & Research. 63, 454-466. 
Smith, C.A. (2016) Evidence-based treatment of chronic kidney disease. Nurse Practitioner. 
41(11). 42-48 doi: 10.1097/01.NPR.0000502790.65984.61 
Staring, A.B., Van den Berg, D.P., Cath, D.C., Schoorl, M., Engelhard, I.M. & Korrelboom, 
C.W. (2016). Self-esteem treatment in anxiety: A randomized controlled crossover trial of Eye 
Movement Desensitization and Reprocessing (EMDR) versus Competitive Memory Training 
(COMET) in patients with anxiety disorders. Behaviour Research and Therapy, 82, 11-20. Doi: 
10.1016/j.brat.2016.04.002 
Shirazian, S., Grant, C.D., Aina, O., Mattana, J., Khorassani & Ricardo, A.C. (2017). Depression 
in chronic kidney disease and end –stage renal disease: similarities and differences in diagnosis, 
epidemiology and management. Kidney International Reports.2, 94-107, doi: 
10.1016/ekir.2016.09.005 
Valiente-Gomez, A., Moreno-Alcazar, A., Treen, D., Cedron, C., Colom., F., Perez., V & 
Amann, B.L. (2017) EMDR beyond PTSD: A systematic literature review. Frontiers in 
Psychology. 8. Article 1668. 10 pages. Doi: 10.3389/fpsyg.2017.01668 
Zigmond, A.S. & Snaith, R.P. (1983). The hospital anxiety and depression scale. Acta 
Psychiatrica Scandinavica, 67, 361-370.  
18 
 
Zhang, M., Kim, J.C., Li, Y., et al. (2014). Relation between anxiety, depression, and physical 
activity and performance in maintenance hemodialysis patients. Journal of Renal Nutrition, 
24,252-260. https://doi.org/10.1007/s13539-014-0131-4. 
 
 
 
  
Assessed for eligibility (n=90) 
Obtaining consent 
Excluded (n=0) 
♦   Not meeting inclusion criteria (n=0) 
 
Analysed (n=45) 
♦ Excluded from analysis (give reasons) (n=0) 
Lost to follow-up (give reasons) (n=0) 
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Allocated to intervention (n= 45) 
♦ Received allocated intervention (n= 45) 
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reasons) (n= 0) 
Lost to follow-up (give reasons) (n=0) 
Discontinued intervention (give reasons) (n= 0) 
Allocated to control (n= 45) 
♦ Received allocated intervention (n= 45) 
♦ Did not receive allocated intervention (give 
reasons) (n=0) 
Analysed (n=45) 
♦ Excluded from analysis (give reasons) (n=0) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n=90) 
Enrollment 
Table 1. Demographic characteristics of the subjects (n = 90)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristic 
 
Total 
(n = 90) 
%(n)  
Intervention  
  (n = 45) 
%(n)  
Control 
 (n = 45) 
%(n)  
 
Statistical 
analysis 
(independent t-
test and Chi-
square test), 
     p-value 
Age (year) 
 
 
51.52±11.134 
 
49.27±13.23 
 
53.38±10.17 
t=-1.65 
p=0.10 
Gender 
Female 
Male 
 
47(52.2) 
43(47.8) 
 
26(55.3) 
19(44.2) 
 
21(44.7) 
24(55.8) 
Fisher’s exact 
df=1 
p=0.390 
Education level 
Lower than diploma   
Diploma and higher 
 
50(55.6) 
40(44.4)  
 
21(46.7) 
24(53.3)  
 
29(64.4) 
16(35.7)  
 
Fisher’s exact 
p=0. 130 
Marital status 
Single 
Married  
Widow 
 
12(13.3) 
68(75.6) 
10(11.1) 
 
7(15.6) 
34(75.6) 
4(8.8) 
 
5(11.1) 
34(75.6) 
6(13.3) 
 
X2=0.73 
df=2 
p=0.690 
Employment status 
Unemployed  
Employed 
Retired 
Housewife 
 
15(16.7) 
21(21.9) 
19(38.9) 
35(38.9) 
 
9(20.0) 
14(31.1) 
7(15.6) 
15(33.3) 
 
6(13.3) 
7(15.6) 
12(26.7) 
20(44.4) 
 
X2=4.96 
df=3 
p=0.170 
Duration of hemodialysis ( M ± SD) 
1-5 
5-10 
>10 year 
 
71(78.9) 
9(10.0) 
10(11.1) 
 
 
36(50.7) 
2(22.2) 
7(70.0) 
 
 
35(49.3) 
7(77.8) 
30(30.0) 
 
 
X2=4.39 
df=2 
p=0.110 
  
 
 
 
 
 
 
 
 
 
 
Table 2. The effect of EMDR on the level of anxiety (n = 90) 
 
Before the intervention 
 (Qualitative)  Group Total Statistical analysis,      p-value Intervention Control 
Normal (Score 0-7) - - - 
Fisher's exact  
P=0.39 
Borderline  (Score 8-10) 19(21.1%) 24(26.7%) 43(47.8%) 
Abnormal (Score of 11-21) 26(28.9%) 21(23.3%) 47(52.2%) 
 (Quantitative)  12.27±3.96 11.07±2.84  Independent t-test t=-1.65,df=79.88,P=0.10 
After the intervention 
Normal (Score 0-7) 23(25.5%) 6(6.7%) 29(32.2%) 
 Chi-square test 
X2(2) =19.07, p=0.01.  
Cramer's V=r=0.46 
Cohen's d=1.03 
Effect sizes=large 
Borderline (Score 8-10) 17(18.9%) 19(21.1%) 36(40%) 
Abnormal (Score 11-21) 5(5.6%) 20(22.2%) 25(27.8%) 
(Quantitative) 7.27±2.84 10.69±3.24  
Independent t-test 
t=-5.32, df=88, P=0.001 
Cohen's d=1.12 
Effect sizes=large 
  
 
 
 
 
 
Table 3. The effect of EMDR on the level of depression (n = 90) 
 
Before the intervention 
(Qualitative) Group Total Statistical analysis,      p-value Intervention Control 
Normal (Score 0-7) - - - 
Fisher's exact  
P=0.20 
Borderline  (Score 8-10) 29(32.2%) 22(24.4%) 51(56.7%) 
Abnormal (Score 11-21) 16(17.8%) 23(25.6%) 39(43.3%) 
 (Quantitative)  10.78±3.32 11.73±3.05  Independent t-test t=1.42,df=88,P=0.15 
After the intervention 
Normal (Score 0-7) 20(22.2%) 5(5.6%) 25(27.8%) 
 Chi-square test 
X2(2) =14.76, p=0.01.  
Cramer's V=r=0.40 
Cohen's d=0.88 
Effect sizes=large 
Borderline  (Score 8-10) 13(14.4%) 13(14.4%) 26(28.8%) 
Abnormal (Score 11-21) 12(13.3%) 27(30%) 39(43.3%) 
(Quantitative) 6.27±2.10 11.33±3.14  
Independent t-test 
t=8.99, df=76.87, P=0.001 
Cohen's d=1.89 
Effect sizes=large 
